StreetAlpha
Kiniksa Pharmaceuticals International, plc · SEC Form 4

KNSA Insider Trading

From SEC Form 479 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Kiniksa Pharmaceuticals International, plc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $122M sold.

← KNSA stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$122M28 sales · 8 insiders
Net−$122Mbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $3.1MDec2026-01: sold $503KJan2026-02: sold $1.6MFeb2026-03: sold $3.5MMar2026-04: sold $28.3MApr2026-05: sold $5.8MMayJun2026-07: sold $299KJulAug2026-09: sold $369KSep2026-10: sold $3.4MOct2026-11: sold $74.8MNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when KNSA insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an KNSA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every KNSA insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 9, 2026Michael R MegnaChief Accounting OfficerSale plan11,280$98.54$1.1M12,697Nov 12Form 4
Nov 4, 2026Sanj K PatelChairman & CEOSale plan151,300$94.71$14.3M774,500Nov 6Form 4
Nov 3, 2026Sanj K PatelChairman & CEOSale plan402,494$92.92$37.4M780,037Nov 3Form 4
Nov 2, 2026John F. PaoliniChief Medical OfficerSale plan96,000$93.09$8.9M69,922Nov 3Form 4
Nov 2, 2026Mark RagosaCFOSale plan36,783$92.16$3.4M20,854Nov 3Form 4
Nov 2, 2026Ross MoatCOOSale plan103,585$92.93$9.6M10,294Nov 3Form 4
Oct 30, 2026Michael R MegnaChief Accounting OfficerSale plan36,260$94.43$3.4M12,697Nov 3Form 4
Sep 3, 2026Michael R MegnaChief Accounting OfficerSale plan4,600$80.30$369K29,062Sep 3Form 4
Jul 29, 2026G Bradley ColeDirectorSale3,673$81.43$299K11,672Jul 31Form 4
May 1, 2026John F. PaoliniChief Medical OfficerSale plan58,424$53.71$3.1M65,623May 5Form 4
May 1, 2026Sanj K PatelChairman & CEOSale plan48,565$54.02$2.6M0May 1Form 4
Apr 30, 2026Sanj K PatelChairman & CEOSale plan508,339$51.96$26.4M0Apr 30Form 4
Apr 28, 2026Barry D QuartDirectorSale plan13,099$50.10$656K12,546Apr 29Form 4
Apr 9, 2026Michael R MegnaChief Accounting OfficerSale plan6,625$46.69$309K27,418Apr 13Form 4
Apr 9, 2026Ross MoatCOOSale plan1,703$46.69$80K12,029Apr 13Form 4
🔒 64 more trades. Create a free account or sign in to see them all.

KNSA insider trading FAQ

Are KNSA insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of KNSA on the open market in 0 trades, and 8 sold $122M in 28 trades, 100% of that under pre-arranged trading plans.

When did an KNSA insider last buy shares?

There has been no open market insider purchase of KNSA in the last two years.

When did an KNSA insider last sell shares?

Michael R Megna (Chief Accounting Officer) sold 11,280 shares for $1.1M on Nov 9, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice